Skip to main content
. 2017 Jan 30;8(15):24469–24482. doi: 10.18632/oncotarget.14905

Figure 1. Nomogram for predicting five- and eight-year.

Figure 1

A. overall survival (OS) and B. cancer-specific survival (CSS) in patients with MSGC. Abbreviations: Grade: I, Well differentiated; II, Moderately differentiated; III, Poorly differentiated; IV, Undifferentiated. Site: P, parotid gland; SM, submandibular gland; SL, sublingual gland. Race: Other, American Indian/AK Native, Asian/Pacific Islander. Instructions: All the points identified on the points scale for each factor were summed up for each patient. This total point score is identified on the bottom scale to determine the probability of five- and eight-year OS or CSS for an individual patient.